why choose us

Clinical Trials Search

Showing 11,910 of 132,963 result(s)
Digital Human-Based Brief Interventions for Harmful Alcohol Use: The PAHOLA Project

Status: NOT_YET_RECRUITING

Condition: Alcohol Drinking

Interventions: Pahola is the Pan American Health Organization's new digital health specialist on alcohol use.
Programmed with the latest information and re

Date: 2023-05-29

Vagus Nerve Stimulation for Autonomic Nervous System Activity

Status: NOT_YET_RECRUITING

Condition: Autonomic Nervous System Imbalance

Interventions: As a vagus stimulation protocol, bilateral auricular stimulation and stimulation frequency of 10 Hz, pulse width of 300 µs, biphasic application for 2

Date: 2023-05-29

Simplification and Test and Treat Strategies Towards Hepatitis C Eliminationplatform" in China(STAT)

Status: NOT_YET_RECRUITING

Condition: Hepatitis C Virus Infection

Interventions:

HCV antibody screening were carried out with rapid diagnostic testings (RDTs) by colloidal gold method, using fingertip blood or residual blood fro

Date: 2023-05-29

Evaluation of the Impact of L- Carnitine in Intradialytic Hypotension in Pediatric Patients on Regular Hemodialysis

Status: ACTIVE_NOT_RECRUITING

Condition: Intradialytic Hypotension

Interventions: L carnitine will be given to group 1 (20 mg;kg;day) 3 times per week

Date: 2023-05-29

Phase I Clinical Study of SPH4336 Tablets in the Treatment of Advanced Solid Tumors

Status: ACTIVE_NOT_RECRUITING

Condition: Advanced Solid Tumors

Interventions: Open-label SPH4336 Tablets ?Administered by oral

Date: 2023-05-29

Establishment of Biomechanical- and AI- Based Rehabilitation Strategies for Pain Inducing Lifestyles

Status: NOT_YET_RECRUITING

Condition: Healthy

Interventions:

Date: 2023-05-29

The Exopulse Mollii Suit Registry - a Database for Routine Follow-up of Clinical Outcomes

Status: NOT_YET_RECRUITING

Condition: Cerebral Palsy

Interventions: The registry is designed to demonstrate the impact of Exopulse Mollii Suit on improvement of muscle relaxation, muscle activation, local blood circula

Date: 2023-05-29

SVRd for the Treatment of Newly Diagnosed Multiple Myeloma Patients Presenting With Extramedullary Disease

Status: Completed

Condition: Multiple Myeloma

Interventions: Selinexor 60 mg;day, orally on d1,8,15,22

Date: 2023-05-29

Enteral Nutrition Guidelines and Patients' Outcomes

Status: NOT_YET_RECRUITING

Condition: Enteral Nutrition

Interventions: The nurses will be educated about the enteral nutrition guidelines.
Then they will apply these guidelines on the participants during enteral nutr

Date: 2023-05-29

Efficacy and Safety of HL-085 Combined With Vemurafenib in BRAF V600E Patients With Non-small Cell Lung Cancer: a Phase II Clinical Study

Status: NOT_YET_RECRUITING

Condition: Non-small-cell Lung Cancer

Interventions: The treatment regimen was HL-085 9mg BID+ Vemurafenib 720mg BID oral administration for 21 days per cycle.
The primary efficacy endpoint in this

Date: 2023-05-29